Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 4 Melanoma 2 Prostatic Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Glioma 1

Interventions

Paclitaxel 5 Etoposide 4 Oxaliplatin 3 Ifosfamide 3 Granulocyte Colony-Stimulating Factor 3 Gemcitabine 3 Cyclophosphamide 3 Cisplatin 3 Carboplatin 3 ribociclib 2 fludarabine 2 etoposide phosphate 2 Stem Cell Transplantation 2 Sirolimus 2 Melphalan 2 Filgrastim 2 Everolimus 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 tozuleristide 1 sonidegib 1 ripretinib 1 pralsetinib 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 pazopanib 1 olaparib 1 interferon gamma-1b 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasms, Germ Cell and Embryonal × Disulfiram × Clear all

NCT03950830 2023-10-04

DISGCT

National Cancer Institute, Slovakia

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡